U.S. Physical Therapy, Inc.

$ 63.32 0.76 %

U.S. Physical Therapy, Inc., through its various subsidiaries, manages a network of outpatient physical therapy facilities. These clinics deliver a range of services, including rehabilitation before and after surgery, treatment for musculoskeletal conditions, recovery from sports-related trauma, proactive health measures, assistance for workers recovering from injuries, and care for neurological conditions. The company's business is divided into two primary divisions: Physical Therapy Operations and Industrial Injury Prevention Services. Within its industrial segment, it provides specialized services like on-site injury avoidance and recovery programs, strategies for enhancing physical performance, pre-employment screening tests, assessments of an individual's work capacity, and workplace ergonomic reviews. These offerings are delivered by licensed physical therapists and expert certified athletic trainers to a diverse clientele, including Fortune 500 corporations, insurance providers, and their associated contractors. By the end of 2021, specifically December 31st, the company had established 591 operational clinics across 39 states, in addition to overseeing 35 other physical therapy sites. Established in 1990, the company maintains its headquarters in Houston, Texas.

CEO: Christopher J. Reading - https://www.usph.com

Price objectif

$96 51.61 %

Recommandation

Buy

DCF

$ 49.50

Loading data...

USPH vs S&P500

Loading data...

No data available.

Quick ratio

1.19

suggests a healthy liquidity position, showing that the company can likely meet its short-term obligations.

P/E ratio

126.64

is considered reasonable, suggesting that the company has a valuation in line with its current profits.

EPS

0.50

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

0.24 %

indicates low profitability, suggesting that the company is not using equity efficiently to generate profits.

ROIC

5.49 %

does not generate enough return to cover its financing costs, which indicates value destruction and may pose long-term profitability issues.

WACC

7.19

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

0.77

indicates that the company uses more equity than debt, suggesting prudent management.

Free cash flow per share

4.41

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

2 318.81 %

indicates that the company is retaining a large portion of its profits to reinvest in growth

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
5 indicates moderate financial health
Altman score
2.33 indicates an uncertain financial situation
Loading data...

No data available.

Cash / Debt

Cash Ratio
0.24 indicates liquidity risk, as the company may not have enough cash to meet its immediate obligations
Debt Ratio
0.29 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.